<p><b>Copyright information:</b></p><p>Taken from "Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis"</p><p>http://arthritis-research.com/content/9/1/R11</p><p>Arthritis Research & Therapy 2007;9(1):R11-R11.</p><p>Published online 31 Jan 2007</p><p>PMCID:PMC1860070.</p><p></p> ***< 0.001 versus placebo logistic regression model unadjusted for multiple comparisons
